Swiss National Bank’s Tourmaline Bio TRML Stock Holding History

Swiss National Bank’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-22,400	Closed	-$1.07M	–	2370
2025 Q3	$1.07M	Hold	22,400	–	–	﹤0.01%	2141
2025 Q2	$358K	Hold	22,400	–	–	﹤0.01%	2328
2025 Q1	$341K	Buy	22,400 +2,300	+11%	+$36.9K	﹤0.01%	2381
2024 Q4	$408K	Buy	+20,100	New	+$506K	﹤0.01%	2418
2024 Q3	–	Sell	-25,200	Closed	-$324K	–	2483
2024 Q2	$324K	Sell	25,200 -6,800	-21%	-$109K	﹤0.01%	2447
2024 Q1	$733K	Buy	+32,000	New	+$1.13M	﹤0.01%	2361

Swiss National Bank's TRML Position: Q4 2025 in Review

Swiss National Bank sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 22,400 shares — an estimated $1.07M sold.

Swiss National Bank first reported a position in TRML in Q1 2024 and held it in 6 quarters. The position peaked at $1.07M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Swiss National Bank reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Swiss National Bank sold 22,400 Tourmaline Bio shares in Q4 2025, an estimated $1.07M.
Swiss National Bank first reported a position in Tourmaline Bio in Q1 2024 and held it in 6 quarters.
Swiss National Bank's Tourmaline Bio position peaked at $1.07M in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Swiss National Bank's 13F filing for Q4 2025, filed 12 Feb 2026.